MEDICAMEN BIOTECH
Back to Balance Sheet
|
MEDICAMEN BIOTECH Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹294 Cr | ₹292 Cr | ₹277 Cr | ₹225 Cr | ₹194 Cr |
What is the latest Total Liabilities ratio of MEDICAMEN BIOTECH ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹294 Cr |
| Mar2024 | ₹292 Cr |
| Mar2023 | ₹277 Cr |
| Mar2022 | ₹225 Cr |
| Mar2021 | ₹194 Cr |
How is Total Liabilities of MEDICAMEN BIOTECH Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹294 Cr | 0.78 | |
| Mar2024 | ₹292 Cr | 5.57 | |
| Mar2023 | ₹277 Cr | 22.84 | |
| Mar2022 | ₹225 Cr | 16.08 | |
| Mar2021 | ₹194 Cr | - | |
Compare Total Liabilities of peers of MEDICAMEN BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MEDICAMEN BIOTECH | ₹308.2 Cr | -16.7% | -22.7% | -41.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,145.0 Cr | -0.1% | -2.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,989.0 Cr | -0.2% | -2.8% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,322.0 Cr | 2.3% | 1.2% | 41.1% | Stock Analytics | |
| CIPLA | ₹112,149.0 Cr | 0.7% | 1.9% | -4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,483.0 Cr | 0.1% | -2.4% | 2.3% | Stock Analytics | |
MEDICAMEN BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MEDICAMEN BIOTECH | -16.7% |
-22.7% |
-41.3% |
| SENSEX | -1% |
-5.7% |
-9.7% |
You may also like the below Video Courses